Loading…
Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate
Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated...
Saved in:
Published in: | PloS one 2021-02, Vol.16 (2), p.e0246735 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3 |
---|---|
cites | cdi_FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3 |
container_end_page | |
container_issue | 2 |
container_start_page | e0246735 |
container_title | PloS one |
container_volume | 16 |
creator | Allison, Abimbola Fouladkhah, Aliyar Cyrus |
description | Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated with about 60% of Shiga toxin-producing E. coli related foodborne illness episodes. Current study evaluated sensitivity of the O157 and epidemiologically important non-O157 serogroups of the pathogen to elevated hydrostatic pressure and 1% lactic acid. Pressure intensity of 250 to 650 MPa were applied for 0 to 7 min for inactivation of strain mixtures of wild-type and rifampicin-resistant E. coli O157, as well as O26, O45, O103, O111, O121, and O145 serogroups and ATCC® 43895™ strain in ground meat and 10% meat homogenate. E. coli O157 were reduced (p < 0.05) from 6.86 ± 0.2 to 4.56 ± 0.1 log CFU/g when exposed to pressure of 650 MPa for 7 min. Corresponding reductions (p < 0.05) for non-O157 E. coli were from 6.98 ± 0.3 to 4.72 ± 0.1. The D-values at 650 MPa were 3.71 and 3.47 min for O157 and non-O157 serogroups, respectively. Presence of 1% lactic acid to a great extent augmented (p < 0.05) decontamination efficacy of the treatment in meat homogenate resulting in up to 5.6 and 6.0 log CFU/mL reductions for O157 and non-O157 serogroups, respectively. Among the tested serogroups, the wild-type and rifampicin-resistant phenotypes exhibited (p ≥ 0.05) comparable pressure sensitivity. Thus, these two phenotypes could be used interchangeably in validation studies. Our results also illustrate that, application of elevated hydrostatic pressure could be utilized for assuring safety of ground and non-intact meat products against various serogroups of Shiga toxin-producing E. coli. Addition of 1% lactic acid additionally provided industrially appreciable augmentation in efficacy of the pressure-based treatments. |
doi_str_mv | 10.1371/journal.pone.0246735 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2491016022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A652227869</galeid><doaj_id>oai_doaj_org_article_5c1e0d83c805469caff297e17081f6b9</doaj_id><sourcerecordid>A652227869</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3</originalsourceid><addsrcrecordid>eNqNk81u1DAQxyMEoqXwBggsISE4ZLGdxE4uSFVVoFKlShS4Wl5nnLhK7NR2SvfleDa8H626qAfkQ5yZ3_zHM_Zk2WuCF6Tg5NOVm72Vw2JyFhaYlowX1ZPskDQFzRnFxdMH-4PsRQhXGFdFzdjz7KAoGMZliQ-zP5dgg4nmxsQVchr9NkObx9UESNoWeaPlOBllbO4hmBCljeiCVHzjtc7mm5_L3nQSRXebuMm7dk4BHToNqgdvVG8kUm4wCUAwwI2M0KJ-1XqX9KJRaEraYfbblINUa5tUpkXGos67OVlHkHHj3mx6N7oObBJ6mT3Tcgjwavc9yn5-Of1x8i0_v_h6dnJ8nivW0Jjrekl1y3nJgTecNxW0BbSaKAyKaFKXzRLXuqkbimXFy6JiAEvKVc2JZFzL4ih7u9WdBhfErvVB0LIhmDBMaSLOtkTr5JWYvBmlXwknjdgYnO-E9KmyAUSlCOC2LlSNq5I1SmpNGw6E45potmyS1uddtnk5QqvARi-HPdF9jzW96NyN4HVDOC2SwIedgHfXM4QoRhMUDIO04ObtuZuSkXKNvvsHfby6HdXJVICx2qW8ai0qjllFKeU1W5978QiVVgujUemdapPsewEf9wISE-E2dnIOQZxdfv9_9uLXPvv-AduDHGIf3DBH42zYB8stqNJrDB70fZMJFusxu-uGWI-Z2I1ZCnvz8ILug-7mqvgLFBQlHQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491016022</pqid></control><display><type>article</type><title>Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Allison, Abimbola ; Fouladkhah, Aliyar Cyrus</creator><contributor>Venkitanarayanan, Kumar</contributor><creatorcontrib>Allison, Abimbola ; Fouladkhah, Aliyar Cyrus ; Venkitanarayanan, Kumar</creatorcontrib><description>Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated with about 60% of Shiga toxin-producing E. coli related foodborne illness episodes. Current study evaluated sensitivity of the O157 and epidemiologically important non-O157 serogroups of the pathogen to elevated hydrostatic pressure and 1% lactic acid. Pressure intensity of 250 to 650 MPa were applied for 0 to 7 min for inactivation of strain mixtures of wild-type and rifampicin-resistant E. coli O157, as well as O26, O45, O103, O111, O121, and O145 serogroups and ATCC® 43895™ strain in ground meat and 10% meat homogenate. E. coli O157 were reduced (p < 0.05) from 6.86 ± 0.2 to 4.56 ± 0.1 log CFU/g when exposed to pressure of 650 MPa for 7 min. Corresponding reductions (p < 0.05) for non-O157 E. coli were from 6.98 ± 0.3 to 4.72 ± 0.1. The D-values at 650 MPa were 3.71 and 3.47 min for O157 and non-O157 serogroups, respectively. Presence of 1% lactic acid to a great extent augmented (p < 0.05) decontamination efficacy of the treatment in meat homogenate resulting in up to 5.6 and 6.0 log CFU/mL reductions for O157 and non-O157 serogroups, respectively. Among the tested serogroups, the wild-type and rifampicin-resistant phenotypes exhibited (p ≥ 0.05) comparable pressure sensitivity. Thus, these two phenotypes could be used interchangeably in validation studies. Our results also illustrate that, application of elevated hydrostatic pressure could be utilized for assuring safety of ground and non-intact meat products against various serogroups of Shiga toxin-producing E. coli. Addition of 1% lactic acid additionally provided industrially appreciable augmentation in efficacy of the pressure-based treatments.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0246735</identifier><identifier>PMID: 33600440</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Agriculture ; Antiinfectives and antibacterials ; Beef ; Biology and Life Sciences ; Chemical properties ; Control ; Decontamination ; Decontamination (from gases, chemicals, etc.) ; Disease control ; Disease prevention ; Drug Resistance, Bacterial - drug effects ; E coli ; Epidemics ; Escherichia coli ; Experiments ; Food chains ; Food inspection ; Foodborne diseases ; Health aspects ; Health risk assessment ; Health surveillance ; Hydrogen-Ion Concentration ; Hydrostatic Pressure ; Inflammatory bowel disease ; Inspection ; Laboratories ; Lactic acid ; Lactic Acid - analysis ; Limit of Detection ; Manufacturing ; Meat ; Meat industry ; Meat processing industry ; Meat Products - analysis ; Medicine and Health Sciences ; Methods ; Microbiology ; Microbiota ; Microbiota - drug effects ; Pathogens ; Phenotype ; Physical Sciences ; Physiological aspects ; Prevention ; Production processes ; Public health ; Rifampin ; Rifampin - pharmacology ; Risk factors ; Shiga toxin ; Shiga-Toxigenic Escherichia coli - drug effects ; Shiga-Toxigenic Escherichia coli - metabolism ; Temperature ; Toxins ; Validation studies ; Yeasts</subject><ispartof>PloS one, 2021-02, Vol.16 (2), p.e0246735</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Allison, Fouladkhah. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Allison, Fouladkhah 2021 Allison, Fouladkhah</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3</citedby><cites>FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3</cites><orcidid>0000-0001-9204-2870</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2491016022/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2491016022?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53770,53772,74873</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33600440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Venkitanarayanan, Kumar</contributor><creatorcontrib>Allison, Abimbola</creatorcontrib><creatorcontrib>Fouladkhah, Aliyar Cyrus</creatorcontrib><title>Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated with about 60% of Shiga toxin-producing E. coli related foodborne illness episodes. Current study evaluated sensitivity of the O157 and epidemiologically important non-O157 serogroups of the pathogen to elevated hydrostatic pressure and 1% lactic acid. Pressure intensity of 250 to 650 MPa were applied for 0 to 7 min for inactivation of strain mixtures of wild-type and rifampicin-resistant E. coli O157, as well as O26, O45, O103, O111, O121, and O145 serogroups and ATCC® 43895™ strain in ground meat and 10% meat homogenate. E. coli O157 were reduced (p < 0.05) from 6.86 ± 0.2 to 4.56 ± 0.1 log CFU/g when exposed to pressure of 650 MPa for 7 min. Corresponding reductions (p < 0.05) for non-O157 E. coli were from 6.98 ± 0.3 to 4.72 ± 0.1. The D-values at 650 MPa were 3.71 and 3.47 min for O157 and non-O157 serogroups, respectively. Presence of 1% lactic acid to a great extent augmented (p < 0.05) decontamination efficacy of the treatment in meat homogenate resulting in up to 5.6 and 6.0 log CFU/mL reductions for O157 and non-O157 serogroups, respectively. Among the tested serogroups, the wild-type and rifampicin-resistant phenotypes exhibited (p ≥ 0.05) comparable pressure sensitivity. Thus, these two phenotypes could be used interchangeably in validation studies. Our results also illustrate that, application of elevated hydrostatic pressure could be utilized for assuring safety of ground and non-intact meat products against various serogroups of Shiga toxin-producing E. coli. Addition of 1% lactic acid additionally provided industrially appreciable augmentation in efficacy of the pressure-based treatments.</description><subject>Acids</subject><subject>Agriculture</subject><subject>Antiinfectives and antibacterials</subject><subject>Beef</subject><subject>Biology and Life Sciences</subject><subject>Chemical properties</subject><subject>Control</subject><subject>Decontamination</subject><subject>Decontamination (from gases, chemicals, etc.)</subject><subject>Disease control</subject><subject>Disease prevention</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>E coli</subject><subject>Epidemics</subject><subject>Escherichia coli</subject><subject>Experiments</subject><subject>Food chains</subject><subject>Food inspection</subject><subject>Foodborne diseases</subject><subject>Health aspects</subject><subject>Health risk assessment</subject><subject>Health surveillance</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydrostatic Pressure</subject><subject>Inflammatory bowel disease</subject><subject>Inspection</subject><subject>Laboratories</subject><subject>Lactic acid</subject><subject>Lactic Acid - analysis</subject><subject>Limit of Detection</subject><subject>Manufacturing</subject><subject>Meat</subject><subject>Meat industry</subject><subject>Meat processing industry</subject><subject>Meat Products - analysis</subject><subject>Medicine and Health Sciences</subject><subject>Methods</subject><subject>Microbiology</subject><subject>Microbiota</subject><subject>Microbiota - drug effects</subject><subject>Pathogens</subject><subject>Phenotype</subject><subject>Physical Sciences</subject><subject>Physiological aspects</subject><subject>Prevention</subject><subject>Production processes</subject><subject>Public health</subject><subject>Rifampin</subject><subject>Rifampin - pharmacology</subject><subject>Risk factors</subject><subject>Shiga toxin</subject><subject>Shiga-Toxigenic Escherichia coli - drug effects</subject><subject>Shiga-Toxigenic Escherichia coli - metabolism</subject><subject>Temperature</subject><subject>Toxins</subject><subject>Validation studies</subject><subject>Yeasts</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk81u1DAQxyMEoqXwBggsISE4ZLGdxE4uSFVVoFKlShS4Wl5nnLhK7NR2SvfleDa8H626qAfkQ5yZ3_zHM_Zk2WuCF6Tg5NOVm72Vw2JyFhaYlowX1ZPskDQFzRnFxdMH-4PsRQhXGFdFzdjz7KAoGMZliQ-zP5dgg4nmxsQVchr9NkObx9UESNoWeaPlOBllbO4hmBCljeiCVHzjtc7mm5_L3nQSRXebuMm7dk4BHToNqgdvVG8kUm4wCUAwwI2M0KJ-1XqX9KJRaEraYfbblINUa5tUpkXGos67OVlHkHHj3mx6N7oObBJ6mT3Tcgjwavc9yn5-Of1x8i0_v_h6dnJ8nivW0Jjrekl1y3nJgTecNxW0BbSaKAyKaFKXzRLXuqkbimXFy6JiAEvKVc2JZFzL4ih7u9WdBhfErvVB0LIhmDBMaSLOtkTr5JWYvBmlXwknjdgYnO-E9KmyAUSlCOC2LlSNq5I1SmpNGw6E45potmyS1uddtnk5QqvARi-HPdF9jzW96NyN4HVDOC2SwIedgHfXM4QoRhMUDIO04ObtuZuSkXKNvvsHfby6HdXJVICx2qW8ai0qjllFKeU1W5978QiVVgujUemdapPsewEf9wISE-E2dnIOQZxdfv9_9uLXPvv-AduDHGIf3DBH42zYB8stqNJrDB70fZMJFusxu-uGWI-Z2I1ZCnvz8ILug-7mqvgLFBQlHQ</recordid><startdate>20210218</startdate><enddate>20210218</enddate><creator>Allison, Abimbola</creator><creator>Fouladkhah, Aliyar Cyrus</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9204-2870</orcidid></search><sort><creationdate>20210218</creationdate><title>Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate</title><author>Allison, Abimbola ; Fouladkhah, Aliyar Cyrus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Agriculture</topic><topic>Antiinfectives and antibacterials</topic><topic>Beef</topic><topic>Biology and Life Sciences</topic><topic>Chemical properties</topic><topic>Control</topic><topic>Decontamination</topic><topic>Decontamination (from gases, chemicals, etc.)</topic><topic>Disease control</topic><topic>Disease prevention</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>E coli</topic><topic>Epidemics</topic><topic>Escherichia coli</topic><topic>Experiments</topic><topic>Food chains</topic><topic>Food inspection</topic><topic>Foodborne diseases</topic><topic>Health aspects</topic><topic>Health risk assessment</topic><topic>Health surveillance</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydrostatic Pressure</topic><topic>Inflammatory bowel disease</topic><topic>Inspection</topic><topic>Laboratories</topic><topic>Lactic acid</topic><topic>Lactic Acid - analysis</topic><topic>Limit of Detection</topic><topic>Manufacturing</topic><topic>Meat</topic><topic>Meat industry</topic><topic>Meat processing industry</topic><topic>Meat Products - analysis</topic><topic>Medicine and Health Sciences</topic><topic>Methods</topic><topic>Microbiology</topic><topic>Microbiota</topic><topic>Microbiota - drug effects</topic><topic>Pathogens</topic><topic>Phenotype</topic><topic>Physical Sciences</topic><topic>Physiological aspects</topic><topic>Prevention</topic><topic>Production processes</topic><topic>Public health</topic><topic>Rifampin</topic><topic>Rifampin - pharmacology</topic><topic>Risk factors</topic><topic>Shiga toxin</topic><topic>Shiga-Toxigenic Escherichia coli - drug effects</topic><topic>Shiga-Toxigenic Escherichia coli - metabolism</topic><topic>Temperature</topic><topic>Toxins</topic><topic>Validation studies</topic><topic>Yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Allison, Abimbola</creatorcontrib><creatorcontrib>Fouladkhah, Aliyar Cyrus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints Resource Center</collection><collection>Science (Gale in Context)</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Source (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ, Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Allison, Abimbola</au><au>Fouladkhah, Aliyar Cyrus</au><au>Venkitanarayanan, Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-02-18</date><risdate>2021</risdate><volume>16</volume><issue>2</issue><spage>e0246735</spage><pages>e0246735-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Various serogroups of Shiga toxin-producing Escherichia coli have been epidemiologically associated with foodborne disease episodes in the United States and around the globe, with E. coli O157: H7 as the dominant serogroup of public health concern. Serogroups other than O157 are currently associated with about 60% of Shiga toxin-producing E. coli related foodborne illness episodes. Current study evaluated sensitivity of the O157 and epidemiologically important non-O157 serogroups of the pathogen to elevated hydrostatic pressure and 1% lactic acid. Pressure intensity of 250 to 650 MPa were applied for 0 to 7 min for inactivation of strain mixtures of wild-type and rifampicin-resistant E. coli O157, as well as O26, O45, O103, O111, O121, and O145 serogroups and ATCC® 43895™ strain in ground meat and 10% meat homogenate. E. coli O157 were reduced (p < 0.05) from 6.86 ± 0.2 to 4.56 ± 0.1 log CFU/g when exposed to pressure of 650 MPa for 7 min. Corresponding reductions (p < 0.05) for non-O157 E. coli were from 6.98 ± 0.3 to 4.72 ± 0.1. The D-values at 650 MPa were 3.71 and 3.47 min for O157 and non-O157 serogroups, respectively. Presence of 1% lactic acid to a great extent augmented (p < 0.05) decontamination efficacy of the treatment in meat homogenate resulting in up to 5.6 and 6.0 log CFU/mL reductions for O157 and non-O157 serogroups, respectively. Among the tested serogroups, the wild-type and rifampicin-resistant phenotypes exhibited (p ≥ 0.05) comparable pressure sensitivity. Thus, these two phenotypes could be used interchangeably in validation studies. Our results also illustrate that, application of elevated hydrostatic pressure could be utilized for assuring safety of ground and non-intact meat products against various serogroups of Shiga toxin-producing E. coli. Addition of 1% lactic acid additionally provided industrially appreciable augmentation in efficacy of the pressure-based treatments.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33600440</pmid><doi>10.1371/journal.pone.0246735</doi><tpages>e0246735</tpages><orcidid>https://orcid.org/0000-0001-9204-2870</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2021-02, Vol.16 (2), p.e0246735 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2491016022 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Acids Agriculture Antiinfectives and antibacterials Beef Biology and Life Sciences Chemical properties Control Decontamination Decontamination (from gases, chemicals, etc.) Disease control Disease prevention Drug Resistance, Bacterial - drug effects E coli Epidemics Escherichia coli Experiments Food chains Food inspection Foodborne diseases Health aspects Health risk assessment Health surveillance Hydrogen-Ion Concentration Hydrostatic Pressure Inflammatory bowel disease Inspection Laboratories Lactic acid Lactic Acid - analysis Limit of Detection Manufacturing Meat Meat industry Meat processing industry Meat Products - analysis Medicine and Health Sciences Methods Microbiology Microbiota Microbiota - drug effects Pathogens Phenotype Physical Sciences Physiological aspects Prevention Production processes Public health Rifampin Rifampin - pharmacology Risk factors Shiga toxin Shiga-Toxigenic Escherichia coli - drug effects Shiga-Toxigenic Escherichia coli - metabolism Temperature Toxins Validation studies Yeasts |
title | Sensitivity of wild-type and rifampicin-resistant O157 and non-O157 Shiga toxin-producing Escherichia coli to elevated hydrostatic pressure and lactic acid in ground meat and meat homogenate |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A27%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sensitivity%20of%20wild-type%20and%20rifampicin-resistant%20O157%20and%20non-O157%20Shiga%20toxin-producing%20Escherichia%20coli%20to%20elevated%20hydrostatic%20pressure%20and%20lactic%20acid%20in%20ground%20meat%20and%20meat%20homogenate&rft.jtitle=PloS%20one&rft.au=Allison,%20Abimbola&rft.date=2021-02-18&rft.volume=16&rft.issue=2&rft.spage=e0246735&rft.pages=e0246735-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0246735&rft_dat=%3Cgale_plos_%3EA652227869%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-f8b2fd7747e797795ed3edf1c0ec1f1849b08f98920a574356eeb27c871a67fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2491016022&rft_id=info:pmid/33600440&rft_galeid=A652227869&rfr_iscdi=true |